BioSpace News Archive

Drug Development

Bristol-Myers Squibb Company Positive Phase 3 Data For Opdivo (Nivolumab) In Advanced Melanoma Patients Previously Treated With Yervoy (Ipilimumab) Presented At The ESMO 2014 Congress; First Phase 3 Results Presented For A PD-1 Immune Checkpoint Inhibitor

September 29, 2014
·
1 min read
Business

Vantage Health Announces Appointment Of Edward Rollins, Former Advisor To Four U.S. Presidents, To Its Board Of Directors

September 29, 2014
·
1 min read
Business

Blue Belt Technologies, Inc. Announces The Addition Of Professor David Barrett To Scientific Advisory Board

September 29, 2014
·
1 min read
Drug Development

Helix Biopharma Initiates Enrollment For Tenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47

September 29, 2014
·
4 min read
Business

Benchworks Collaborates With Boston Therapeutics, Inc. To Market Sugardown®

September 29, 2014
·
5 min read
Business

NEC Corporation To Market SomaLogic, Inc.’s Somascan™ Assay In Japan

September 29, 2014
·
1 min read
BioMidwest

NanoLogix, Inc. Technology Cited In UNITAID Annual Report On TB, Through The World Health Organization

September 29, 2014
·
1 min read
Genomic Health, Inc. Release: The Oncotype DX® Test And Precision Oncology: New Data Presented At ESMO Further Demonstrate Genomic Health’s Successful Approach To Understanding Tumor Biology

September 29, 2014
·
1 min read
Novogen Limited Release: Graham Kelly Phd, CEO & Chairman Attended The Rodman & Renshaw 16th Annual Global Investment Conference

September 29, 2014
·
2 min read
Business

Cerulean Pharma Inc. Appoints General Counsel

September 29, 2014
·
3 min read